Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:907 (15 October), doi:10.1136/bmj.331.7521.907
| The first 150 words of the full text of this article appear below. |
EDITORIn Hungary the HIV risk environment is not quite as severe as in Russia and the west Balkans, and the macro-environmental (especially economic and social) components are not the same.1 Hungary did not experience the rapid changes in its population; the collapse of its healthcare and welfare systems; or the precipitous economic, social, and cultural crises that took place in Russia. Hungarian drug policy, which contains elements of harm reduction, will also contribute to preventing the massive spread of infectious diseases. For example, qualitative studies on injecting drug users in Hungary underline the importance of unlimited availability of injecting equipment in pharmacies and the help of needle exchange programmes (which are, however, available only in bigger cities).2
Although the HIV prevalence is zero among injecting drug users, the prevalence of hepatitis C is about 30-35%. According to our experience, the HIV testing is wide-spread, but the opportunities for
-->
József Rácz, researcher, psychiatrist
Institute for Psychology, Victor Hugo 18-22, Budapest-1132, Hungary raczj@t-online.hu